000 01505 a2200385 4500
005 20250515052456.0
264 0 _c20070417
008 200704s 0 0 eng d
022 _a0009-8981
024 7 _a10.1016/j.cca.2006.10.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aTsuji, Daisuke
245 0 0 _aTherapeutic evaluation of GM2 gangliosidoses by ELISA using anti-GM2 ganglioside antibodies.
_h[electronic resource]
260 _bClinica chimica acta; international journal of clinical chemistry
_cMar 2007
300 _a38-41 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAntibodies, Monoclonal
_xtherapeutic use
650 0 4 _aCells, Cultured
650 0 4 _aEnzyme-Linked Immunosorbent Assay
_xmethods
650 0 4 _aFibroblasts
_xchemistry
650 0 4 _aG(M2) Ganglioside
_xanalysis
650 0 4 _aGangliosidoses, GM2
_xtherapy
650 0 4 _aHexosaminidase B
650 0 4 _aHumans
650 0 4 _aSandhoff Disease
_xtherapy
650 0 4 _aTay-Sachs Disease
_xtherapy
650 0 4 _abeta-Hexosaminidase beta Chain
650 0 4 _abeta-N-Acetylhexosaminidases
_xtherapeutic use
700 1 _aHigashine, Yukari
700 1 _aMatsuoka, Kazuhiko
700 1 _aSakuraba, Hitoshi
700 1 _aItoh, Kohji
773 0 _tClinica chimica acta; international journal of clinical chemistry
_gvol. 378
_gno. 1-2
_gp. 38-41
856 4 0 _uhttps://doi.org/10.1016/j.cca.2006.10.010
_zAvailable from publisher's website
999 _c16763373
_d16763373